menu
    • menu

    Company profile for Khondrion

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Khondrion is a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial disease. Founded by Professor Jan Smeitink, a world-leader in mitochondrial medicine, the company is advancing its proprietary science through a wholly-owned clinical and preclinical small molecule pipeline of potential medicines.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    KhondrionNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Philips van Leydenlaan 15, 6525 EX, Nijmegen
    Telephone
    Telephone
    +31 24 361 75 05
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.khondrion.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Khondrion secures 5M innovation credit, funding for Phase 3 trial
    Khondrion secures 5M innovation credit, funding for Phase 3 trial

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/khondrion-secures-up-to-5-million-innovation-credit-from-dutch-government-plus-additional-funding-from-current-investors-to-advance-phase-3-clinical-trial-in-m3243ag-primary-mitochondrial-disease-302445066.html

    PR NEWSWIRE
    06 May 2025
    Share Share
    UMDF & Khondrion Announce Investment to Advance Mitochondrial Drug
    UMDF & Khondrion Announce Investment to Advance Mitochondrial Drug

    21 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/21/2985091/0/en/UMDF-and-Khondrion-Announce-The-Mito-Fund-s-Investment-in-Khondrion-to-Support-Development-of-One-of-the-Most-Advanced-Drug-Candidates-for-Primary-Mitochondrial-Disease.html

    GLOBENEWSWIRE
    21 Nov 2024
    Share Share
    Khondrion Receives FDA Clearance for Sonlicromanol Phase 3
    Khondrion Receives FDA Clearance for Sonlicromanol Phase 3

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2981036/0/en/Khondrion-receives-FDA-clearance-of-IND-application-for-pivotal-Phase-3-clinical-trial-of-sonlicromanol-for-the-treatment-of-primary-mitochondrial-disease.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share
    Khondrion's Ph 2b Data on Sonlicromanol in Mitochondrial Disease
    Khondrion's Ph 2b Data on Sonlicromanol in Mitochondrial Disease

    07 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/07/2976519/0/en/Khondrion-announces-publication-in-Brain-of-integrated-Phase-2b-program-demonstrating-disease-modifying-potential-of-sonlicromanol-in-primary-mitochondrial-disease.html

    GLOBENEWSWIRE
    07 Nov 2024
    Share Share
    Khondrion appoints Jasper Levink as Chief Financial and Business Officer
    Khondrion appoints Jasper Levink as Chief Financial and Business Officer

    11 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/11/2944373/0/en/Khondrion-appoints-Jasper-Levink-as-Chief-Financial-and-Business-Officer.html

    GLOBENEWSWIRE
    11 Sep 2024
    Share Share
    Khondrion announces grant of patents in the US and Europe for sonlicromanol
    Khondrion announces grant of patents in the US and Europe for sonlicromanol

    01 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/khondrion-announces-grant-of-patents-in-the-us-and-europe-for-its-lead-candidate-sonlicromanol-covering-the-anti-inflammatory-effect-on-mpges-1-301973246.html

    PR NEWSWIRE
    01 Nov 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search